These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Jun 5, 2012Routinely exhibiting unprecedented speed, quality and success, Pfēnex Expression TechnologyTM enables biopharmaceutical development
San Diego, CA, June 5, 2012 Based on its comprehensive TEAM Research™ rigorous 10 step evaluation methodology, Frost & Sullivan has awarded Pfenex Inc. with the 2012 North American Enabling...
-
May 1, 2012Funding will be provided by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.
San Diego, CA, May 1, 2012 Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has...
-
Mar 1, 2012Pfenex Inc. and DNA2.0 to develop an optimized design and synthesis process for genex expressed in Pfenex Expression Technology
San Diego, Calif. and Menlo Park, Calif., March 1, 2012—Pfenex Inc., an industry leader in protein expression through the Pfēnex Expression Technology™ platform, announced today that it...
-
Jan 10, 2012Companies announce a multi-year, multi-product relationship and will collaborate to develop, manufacture, market and sell value added proteins for use in the research and diagnostic market
San Diego, CA and Hayward, CA January 10, 2012 – Pfenex Inc. and ProZyme, Inc. today announced that they have entered into a joint collaboration and supply agreement. Under the terms of the...
-
Sep 6, 2011
San Diego, CA – September 6, 2011 – Pfenex has been named by FierceBiotech today as one of 2011’s Fierce 15, designating it as one of the most promising private biotechnology...
-
Jun 7, 2011Strategic Alliance will strengthen technology capabilities in the areas of microbial strain engineering, production of complex protein therapeutics and bioconjugation
San Diego, California June 7, 2011 – Pfenex Inc., an industry leader in protein expression through thePfēnex Expression Technology™ platform, announced today that it has entered into a...